학술논문

Seroprevalence of Specific SARS-CoV-2 Antibodies during Omicron BA.5 Wave, Portugal, April–June 2022
Document Type
article
Source
Emerging Infectious Diseases, Vol 29, Iss 3, Pp 590-594 (2023)
Subject
COVID-19
2019 novel coronavirus disease
coronavirus disease
severe acute respiratory syndrome coronavirus 2
SARS-CoV-2
viruses
Medicine
Infectious and parasitic diseases
RC109-216
Language
English
ISSN
1080-6040
1080-6059
Abstract
After the rapid spread of SARS-CoV-2 BA.5 Omicron lineage in Portugal, we developed a seroepidemiologic survey based on a sample of 3,825 residents. Results indicated that from April 27 through June 8, 2022, the estimated seroprevalence of SARS-CoV-2 nucleocapsid or spike IgG was 95.8%, which indicates a high level of protection.